domingo, 30 de enero de 2022

SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys - The Lancet Respiratory Medicine

SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys - The Lancet Respiratory Medicine

No hay comentarios:

Publicar un comentario